Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
about
International Consensus Document (ICON): Common Variable Immunodeficiency DisordersFollicular Bronchiolitis: A Literature ReviewMechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary ImmunodeficienciesGastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings.Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiencyLung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies.Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases.Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiencyA review on guidelines for management and treatment of common variable immunodeficiency.Laboratory diagnosis of primary immunodeficiencies.Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.Autoimmunity and Primary Immunodeficiency Disorders.Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.Lung Disease in Primary Antibody Deficiencies.An Update on the Use of Immunomodulators in Primary Immunodeficiencies.Chronic lung disease in common variable immune deficiency (CVID): A pathophysiological role for microbial and non-B cell immune factors.An unusual cause of fever in a patient with common variable immunodeficiency.The Lung in Dysregulated States of Humoral Immunity.Primary Immunodeficiency Diseases: Current and Emerging Therapeutics.FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency.Autoimmunity/inflammation in a monogenic primary immunodeficiency cohortIntravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters.Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.[Common variable immunodeficiency: a clinical challenge].Bronchus-associated Lymphoid Tissue in Kabuki Syndrome with Associated Hyper-IgM Syndrome/Common Variable Immunodeficiency.Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets.Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.Granulomatous-Lymphocytic Interstitial Lung Disease in 22q11.2 Deletion Syndrome: a Case Report and Literature Review.Common variable immunodeficiency (CVID): new genetic insight and unanswered questions.The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation
P2860
Q26777304-497FA8CE-5114-4FE4-A0B3-67CDB4768552Q26779104-E44607D6-3E4B-403C-B993-094C4CFC8D9FQ28066193-51C42C05-FC06-4A49-B0B2-56DBBC1D9CB7Q28072810-98236E76-04EF-4538-9690-BEF3C5B48BB0Q30245322-B3C0FC75-1CB6-425D-8889-87D439872A66Q33425862-CB772192-9183-4AE0-9BEE-5579DB43B567Q33942410-545F4D56-56A3-4291-AF67-B68DEDBA15F4Q35851600-23AE70A5-8B9F-4E0F-99C9-010BD23141D2Q36011831-6B2B01E8-6299-44C5-B62E-884E84C70B66Q36900160-6042BC6F-2E02-4BDB-BB9F-ED1FD3366003Q38111423-CA0C4CD4-FD41-46A6-9CDC-1A9893BB2A23Q38191164-C4531DB6-A9BC-4081-9B05-5F31EE0A1386Q38726509-8CC2BB9E-FE62-45BB-B277-9D952BAF2006Q38841123-89379D33-7E04-4433-9E97-921BA7ED4F31Q38874082-10700B64-ADF2-4DAC-B973-A51B2E3E3743Q39005508-089FD8A6-19FE-4293-B762-F45CED033914Q39016299-1270AA90-07A0-4F70-86E7-494CA3B322D2Q39077092-5B9CB054-54B3-4DC1-92F3-2F8115978754Q40039791-7824E1C7-7D59-462C-A803-E01482ECA5F4Q40045962-9275DEA8-522A-445B-9DFD-1E0A62B6CCC6Q40076704-F89F248F-D1E9-4EA8-95DF-973F290D7745Q40431689-57A3FCCA-69C4-4E42-95E0-9B863EA6C11BQ40635508-1B2EF6DF-11DA-4EE7-B2E8-E0EAD440FE24Q41990559-AB300EDF-2FEC-4851-8E7C-229FD8213ECCQ41990601-C1AED8AB-AD71-4E8E-AC76-DF3DA0C5D114Q41996711-36BE47A3-85D8-40CB-A3CA-3EAFF3D869AEQ42209502-03671BA6-60B3-4909-8B8A-6FBBF24A7228Q43793814-BBE64ADB-CBBF-474F-BB99-55E038323726Q45781154-2077118B-0BF2-45E3-9985-D377973995F7Q49431149-360C56DD-9110-414B-892A-B6818C9FEDBCQ49469643-A410BB73-909D-4D29-9ECB-CD102E9CB642Q50656752-864DDB1D-D25E-4DA1-9AC7-5C9A0F65E664Q51515479-F184B2A9-8C18-4EB0-981D-8EF2012C605DQ52730992-23E74535-6BBF-4D24-B609-75D12D948E90Q54299709-4DACE293-4E50-41EC-B5CA-F35E767D5CC0Q58795403-AB96DB82-009A-44F9-8662-CC50977818AB
P2860
Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@ast
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@en
Use of combination chemotherap ...... ytic interstitial lung disease
@nl
type
label
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@ast
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@en
Use of combination chemotherap ...... ytic interstitial lung disease
@nl
prefLabel
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@ast
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@en
Use of combination chemotherap ...... ytic interstitial lung disease
@nl
P2093
P2860
P1476
Use of combination chemotherap ...... iable immunodeficiency (CVID).
@en
P2093
A Craig Mackinnon
Aoy Tomita-Mitchell
James T Casper
James W Verbsky
Jill K Waukau
John M Routes
Kaushik S Shahir
Lawrence R Goodman
Mary K Hintermeyer
Melodee L Nugent
P2860
P2888
P356
10.1007/S10875-012-9755-3
P577
2012-08-29T00:00:00Z
P6179
1020769268